Thomas Dalle Email & Phone Number

Paris, Fr

Paris, Île-De-France, Fr

Inotrem is a clinical-stage biotech focused on innate immunity, co-founded by Jean-Jacques Garaud, former head of R&D and CMO of the Roche Group. It has raised over 70 million dollars and is backed by Sofinnova and Andera, the two main VC funds in Life Sciences in France.• Reported directly to the CEO and took on several responsibilities as his right-hand• Managed the outreach, organized meetings and managed the business relationships with +50 pharma companies and +70 VC investors across Europe, the US, and Asia, including conducting due diligence procedures for +15 parties, to find partners for future stages of clinical development.• Developed a sophisticated business valuation model and value-sharing models for out-licensing agreements • Managed the work with external parties, ten investment banks, two BD consultants, four market research and market access consultants, and four experts on design and video to help the company build its effort• Arranged Inotrem’s participation in 14 Life Science conferences, including the biggest two (JPMorgan and BIO)• Created the corporate presentations and videos and prepared the bi-monthly Executive Committee meetings: revamped the structure, prepared the agenda, slides, and minutes, and followed up on the action points defined during the meetings

Saint-Malo, Fr

The Roullier group, created in 1959, is an international and independant family group, specialized in plant, animal and human nutrition. With 8 000 employees and a turnover of 4 billion euros, it is present in 50 countries and selling its products in more than 120 countries.Reporting directly to Daniel Roullier, Founder and President of the Supervisory Board : • Consulting : Produced analyses for new strategic business development opportunities to help the decision making of the Founder and the Supervisory Board • Intrapreneurship and innovation : developed from early stage up to launch a strategic innovative biotech product range for agriculture with a strong link to R&D : assessed opportunities, go-to-market strategy, lead the projects, managed the bottlenecks, the pricing, the deals, launch of the products in 15 countries• Managed transversally an international cross-functional team (R&D, Industrialisation, Marketing, Business development, Finance, CEO, legal, compliance) in 15 countries in Europe, North America and Latin America• Managed these complex projects 50% faster than other Group product developments • Reported directly to Daniel Roullier, the founder of the Group

Saint-Malo, Fr

The Roullier group, created in 1959, is an international and independant family group, specialized in plant, animal and human nutrition. With 8 000 employees and a turnover of 2,5 billion euros in 2017, it is present in 50 countries and selling its products in more than 120 countries.Mission : secure the entire sales cycle of the subsidiaries to accompany them in their development • Managed the scoring project : developed from early stage up to implementation with an international team (CFO, Credit Managers, IT) an assessment tool of our agriculture clients tailored to each subsidiary to favor business development by promoting autonomy and decision making ; implemented in 32 countries today• Managed the Group credit reporting project to visualize subsidiaries at risk : developed from early stage up to implementation with a cross-functional team (CFO, consultants, IT), implemented in the whole Group today • Audited the credit risk exposure in the subsidiaries and formulated recommandations• Negotiated deals with insurers to secure sales to promote business development• Evaluated the sales processes in 35 countries, from business approach to recovery• Created risk management tools for CFOs and credit managers• Trained subsidiaries CEOs, CFOs and credit managers

Gb

Missions of financial audit. Mining, industrial & public sector companies, NGOs, banks, retail, healthcare clinics…• Audited the financial statements and provided qualitative reviews of financial information • Analysed the environment & strategy of the company • Assessed the risks and relevancy of the internal control systems• Managed, developed and coached teams

New York, New York, Us

Reported directly to the Managing Director covering French banks and insurance companies• Coordinated the new products offering with cross-functional teams (structuring, trading, legal and compliance departments)• Prepared the marketing of structured products (equity market, commodities…) and new savings products

New York, New York, Us

• Contributed actively to the report « 330 projects to change the World », a reference document for investors• Worked on financial models and built charts for research reports• Built valuation sheets

Paris La Défense Cedex, Fr

• Performed peer analysis and wrote reports for the top management :summary of equity research on the Oil & Gas sector from 25 brokers, earnings estimates consensus• Prepared financial results and strategic presentations: benchmarked competitors, organized roadshows for the team, proofread the financial reports with tight deadlines • Financial information : analysed the financial releases from competitors, calculated financial ratios

Master In Management ('Grande Ecole' Program), Finance, Général

Bachelor In Life Sciences

Courses From The Master In Biopharmaceutical Management

The Science And Business Of Biotechnology (15.480X) By Andrew Lo And Harvey Lodish

Pgp Program (Exchange Program), Management